Filing Details
- Accession Number:
- 0001104659-23-005744
- Form Type:
- 13G Filing
- Publication Date:
- 2023-01-22 19:00:00
- Filed By:
- Laukien Joerg C
- Company:
- Bruker Corp (NASDAQ:BRKR)
- Filing Date:
- 2023-01-23
- SEC Url:
- 13G Filing
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
---|---|---|---|---|---|---|
Joerg C. Laukien | 7,515,769 | 0 | 7,515,769 | 0 | 7,515,769 | 5.1% |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. )*
Bruker Corporation
(Name of Issuer)
Common Stock
(Title of Class of Securities)
116794108
(CUSIP Number)
December 31, 2022
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
¨Rule 13d-1(b)
¨Rule 13d-1(c)
xRule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP NO. 116794108 | 13G | Page 2 of 5 |
1 | NAME OF REPORTING PERSONS
Joerg C. Laukien | ||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) ¨ (b) ¨
| ||
3 | SEC USE ONLY
| ||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION
Germany | ||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER
7,515,769 shares
| |
6 | SHARED VOTING POWER
0 | ||
7 | SOLE DISPOSITIVE POWER
7,515,769 shares
| ||
8 | SHARED DISPOSITIVE POWER
0 | ||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7,515,769 shares
| ||
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)
| ||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.1%
| ||
12 | TYPE OF REPORTING PERSON (See Instructions)
IN
| ||
Item 1 (a). | Name of Issuer: | Bruker Corporation |
Item 1 (b). | Address of Issuer’s Principal Executive Offices: |
40 Manning Road
Billerica, MA 01821
Item 2 (a). | Name of Person Filing: | Joerg C. Laukien |
Item 2 (b). | Address of Principal Business Office or, if none, Residence: |
Markgrafenstrasse 34
76530 Baden-Baden
Germany
Item 2 (c). | Citizenship: | Germany |
Item 2 (d). | Title of Class of Securities: | Common Stock, par value $0.01 per share. |
Item 2 (e). | CUSIP Number: | 116794108 |
Item 3. | If this Statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a: Not applicable. |
(a) | ¨ | Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o); |
(b) | ¨ | Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); |
(c) | ¨ | Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); |
(d) | ¨ | Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); |
(e) | ¨ | An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); |
(f) | ¨ | An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); |
(g) | ¨ | A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); |
(h) | ¨ | A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); |
(i) | ¨ | A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); |
(j) | ¨ | A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J); |
(k) | ¨ | Group, in accordance with §240.13d-1(b)(1)(ii)(K). |
Page 3 of 5
Item 4. | Ownership |
(a) | Amount beneficially owned: | 7,515,769 shares |
(b) | Percent of class: | 5.1% |
The percentage of Common Stock is based upon 147,082,724 shares outstanding as of November 1, 2022, as indicated by Bruker Corporation in its Form 10-Q for the period ended September 30, 2022.
(c) | Number of shares as to which such person has: |
(i) | Sole power to vote or to direct the vote | 7,515,769 shares |
(ii) | Shared power to vote or to direct the vote | 0 |
(iii) | Sole power to dispose or to direct the disposition of | 7,515,769 shares |
(iv) | Shared power to dispose or to direct the disposition of | 0 |
Item 5. | Ownership of Five Percent or Less of a Class |
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].
Item 6. | Ownership of More than Five Percent on Behalf of Another Person |
Not applicable.
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person |
Not applicable.
Item 8. | Identification and Classification of Members of the Group |
Not applicable.
Item 9. | Notice of Dissolution of Group |
Not applicable.
Item 10. | Certification |
Not applicable.
Page 4 of 5
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: January 23, 2023
/s/ Joerg C. Laukien | |
Joerg C. Laukien |
Page 5 of 5